Clinical Care


IDF Diabetes Atlas reveals high burden of hyperglycaemia in pregnancy

Hyperglycaemia is one of the most prevalent metabolic disorders occurring during pregnancy. It can be a result of either existing diabetes in a pregnant woman or the development of insulin resistance and hyperglycaemia during pregnancy.

Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) 2014 - fact, frustration and future needs

The concept of gestational diabetes mellitus (GDM) or hyperglycaemia in pregnancy has long been recognised but is still the subject of much controversy.1 Many different screening protocols and clinical guidelines exist, but no international consensus, and even within countries there is considerable confusion as to what constitutes best practice.

Debate - Insulin pump therapy: a matter of choice?

Psychological challenges for children living with diabetes

Diana Naranjo and Korey Hood

Caregiver reports of provider recommended frequency of blood glucose monitoring and actual testing frequency for youth with type 1 diabetes


Joyce P. Yi-Frazier and colleagues for the SEARCH for Diabetes in Youth Study Group

Guidelines for type 2 diabetes - designed to help newly diagnosed children and adolescents

The prevalence of childhood obesity has increased dramatically worldwide with potentially dire consequences to the health of children and to their future. Drs. Warren Lee of Singapore and Stuart Brink of the USA introduce the new American Academy of Pediatrics guidelines for newly diagnosed type 2 diabetes in children and adolescents, explaining how the evidence-based recommendations are essential for all physicians involved in the care of children.

W.A.S.H. away the world’s dietary salt

The world’s current dietary salt consumption, more than twice the daily amount recommended, is rubbing the wound of declining public health. Increasing evidence suggests that a high salt intake may directly increase the risk of heart disease, stroke, obesity through soft drink consumption, and many other preventable diseases, including cancers. Restricting dietary salt is even more critical for high-risk populations, such as diabetes.

Debate: How low can you go? The low-down on the low carbohydrate debate in type 1 diabetes nutrition

As a means of representing relevant issues to the diabetes community, Diabetes Voice will be providing a forum in which experts can examine controversial issues and provide an argument supporting their point of view. The low carbohydrate debate marks the first in a series of many more to come.

Anthropometric indicators of obesity for identifying cardiometabolic risks in a rural Bangladeshi population – Chandra Diabetes Study

Professor Akhtar Hussain’s aim of studying anthropometric indicators of obesity was to evaluate the predictive ability of body mass index, waist circumference, waist-to-hip ratio, waist-to-height ratio and body fat percentages for the presence of cardiometabolic risks—namely type 2 diabetes, hypertension, dyslipidemia and the metabolic syndrome.

SGLT2 inhibitors – a useful addition to therapy?

SGLT2 stands for ‘sodium-glucose linked transporter 2’. This is a protein within the kidney tubules that regulates the reabsorption of glucose in the kidney. There is also, predictably, an SGLT1, which is present in both the kidney and the gut. In the kidneys, under normal circumstances, virtually all the glucose that passes into the urine from the blood is reabsorbed by the action of SGLT2.